Kevin Weil, who led OpenAI for Science, has launched Warp Sciences with $215M led by Lightspeed, valuing it at $865M, Bloomberg reported. It is building an automated lab in the US for a drug...
Kevin Weil, the former OpenAI executive who led the ChatGPT maker’s AI-for-science efforts, is launching a new startup aimed at using artificial intelligence to speed up a key step of drug...
Warp Sciences brings expert chemists, AI, and robotics together to help biotech and pharma firms speed up drug discovery
Designing a promising molecule is only the beginning of drug research. Someone still has to make it, test it, and turn the results into a better next experiment. Warp Sciences is betting that this...
Wearing cameras and sensor gloves, the startup’s human chemists will train robots to perform various lab tasks.
First reported:
First saved on ClustZ:
Coverage updated:
We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.